Cargando…

Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast Cancer

PURPOSE: The basic helix-loop-helix transcription factor (bHLH) transcription factor Twist1 plays a key role in embryonic development and tumorigenesis. p53 is a frequently mutated tumor suppressor in cancer. Both proteins play a key and significant role in breast cancer tumorigenesis. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yong-Qu, Zhang, Fan, Zeng, Yun-Zhu, Chen, Min, Huang, Wen-He, Wu, Jun-Dong, Chen, Wei-Ling, Gao, Wen-Liang, Bai, Jing-Wen, Yang, Rui-Qin, Zeng, Huan-Cheng, Wei, Xiao-Long, Zhang, Guo-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263931/ https://www.ncbi.nlm.nih.gov/pubmed/34249678 http://dx.doi.org/10.3389/fonc.2021.628814

Ejemplares similares

Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation
por: Zhang, Yong-Qu, et al.
Publicado: (2015)

Wilms Tumor 1 Mutations Are Independent Poor Prognostic Factors in Pediatric Acute Myeloid Leukemia
por: Wang, Yin, et al.
Publicado: (2021)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma
por: He, JingSong, et al.
Publicado: (2021)

Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis
por: Liu, Yu, et al.
Publicado: (2020)

Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients
por: Wen, Wei, et al.
Publicado: (2022)

TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma
por: Zeng, Yun-Zhu, et al.
Publicado: (2021)

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma
por: Zeng, Yun-Zhu, et al.
Publicado: (2021)

MicroRNA-483-5p Predicts Poor Prognosis and Promotes Cancer Metastasis by Targeting EGR3 in Nasopharyngeal Carcinoma
por: Li, Xi-Zhao, et al.
Publicado: (2021)

Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma
por: Zhang, Xue-wen, et al.
Publicado: (2020)

STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
por: Hu, Shanshan, et al.
Publicado: (2020)

Long noncoding RNA ATB promotes the epithelial−mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer
por: Li, Rong-Hui, et al.
Publicado: (2018)

Up-Regulation of hsa-miR-210 Promotes Venous Metastasis and Predicts Poor Prognosis in Hepatocellular Carcinoma
por: Ji, Jia, et al.
Publicado: (2018)

Assessment of the Novel, Practical, and Prognosis-Relevant TNM Staging System for Stage I-III Cutaneous Melanoma
por: Hu, Di, et al.
Publicado: (2022)

Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Breast Cancer: A Propensity Score-Matching Study
por: Hua, Xin, et al.
Publicado: (2020)

Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas
por: Liu, Jing, et al.
Publicado: (2012)

Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer
por: Zhao, Yang, et al.
Publicado: (2021)

USP20 is a predictor of poor prognosis in colorectal cancer and associated with lymph node metastasis, immune infiltration and chemotherapy resistance
por: Jin, RuiRi, et al.
Publicado: (2023)

Correction: Cytoplasmic Skp2 Expression Is Associated with p-Akt1 and Predicts Poor Prognosis in Human Breast Carcinomas
por: Liu, Jing, et al.
Publicado: (2013)

DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
por: Zhou, Fang, et al.
Publicado: (2023)

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL
por: Wang, Lu-Lu, et al.
Publicado: (2021)

SKA1/2/3 is a biomarker of poor prognosis in human hepatocellular carcinoma
por: Song, Guo-Qiang, et al.
Publicado: (2022)

A Weighted Gene Co-Expression Network Analysis–Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer
por: Chen, Qingchuan, et al.
Publicado: (2021)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast Cancers
por: Wang, Chen-Yun, et al.
Publicado: (2022)

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma
por: Chan-Jun, Zhen, et al.
Publicado: (2023)

Corrigendum: A Weighted Gene Co-Expression Network Analysis–Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer
por: Chen, Qingchuan, et al.
Publicado: (2021)

Construction and validation of a prognostic model for hepatocellular carcinoma: Inflammatory ferroptosis and mitochondrial metabolism indicate a poor prognosis
por: Han, Fang, et al.
Publicado: (2023)

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
por: Kim, Michael Paul, et al.
Publicado: (2015)

FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis
por: Zheng, Yi-Wen, et al.
Publicado: (2020)

HDAC10 Is Positively Associated With PD-L1 Expression and Poor Prognosis in Patients With NSCLC
por: Liu, Xiaomei, et al.
Publicado: (2020)

Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015)

Down-regulated expression of CDK5RAP3 and UFM1 suggests a poor prognosis in gastric cancer patients
por: Lin, Mi, et al.
Publicado: (2022)

Enhancer RNA LINC00242-Induced Expression of PHF10 Drives a Better Prognosis in Pancreatic Adenocarcinoma
por: Tong, Wen, et al.
Publicado: (2022)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

Clinical independent prognostic factors and overall survival prognostic nomogram for intracranial subependymoma: A SEER population-based analysis 2004–2016
por: Zhang, Zibin, et al.
Publicado: (2022)

Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients
por: Guan, Xiaoqing, et al.
Publicado: (2021)

High systemic immune-inflammation index predicts poor prognosis and response to intravesical BCG treatment in patients with urothelial carcinoma: a systematic review and meta-analysis
por: Liu, Wen, et al.
Publicado: (2023)

High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma
por: Xiong, Yujia, et al.
Publicado: (2021)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Localization of GPSM2 in the Nucleus of Invasive Breast Cancer Cells Indicates a Poor Prognosis
por: Deng, Mingming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jhbffijidik113rq25u1sjnev8